about
Antihistamines and birth defects: a systematic review of the literature.Managing pregnancy in inflammatory rheumatological diseasesPharmacotherapy of Zollinger-Ellison syndrome.First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth.Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesZollinger-Ellison syndrome: recent advances and controversies.Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.
P2860
Q27348110-E3B481B2-A6DA-491B-9D04-9F698A49BDA0Q35169341-3F8A7BEB-8EC3-452F-9524-55D3043F6E90Q36632665-1FA6ED56-10FF-4373-B8DA-D2CC72C47545Q36647402-15DFB5C7-DEA6-417E-8103-17C11B20266AQ37178591-015D284E-EAFA-4C6C-AFE8-FA453AF51B62Q38150165-AE98C40D-B412-49D6-AFC8-0A82A4A0C57FQ41652270-083FA14E-8E64-4120-8096-312826FE8453
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The safety of H(2)-blockers use during pregnancy.
@en
type
label
The safety of H(2)-blockers use during pregnancy.
@en
prefLabel
The safety of H(2)-blockers use during pregnancy.
@en
P2093
P2860
P356
P1476
The safety of H(2)-blockers use during pregnancy.
@en
P2093
Amalia Levy
Arnon Wiznitzer
Elia Uziel
Gideon Koren
Ilan Matok
Rafael Gorodischer
P2860
P356
10.1177/0091270009350483
P577
2009-09-29T00:00:00Z